The Francis Crick Institute
Browse
journal.pmed.1003771 (1).pdf (215.1 kB)

ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.

Download (215.1 kB)
journal contribution
posted on 2021-10-20, 10:12 authored by Christopher Abbosh, Charles Swanton
Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.

Funding

Crick (Grant ID: 10169, Grant title: Swanton FC001169) Novo Nordisk UK Research Foundation (Grant ID: NNF15OC0016584, Grant title: NovoNordisk Foundation 16584) European Research Council (Grant ID: 835297 - PROTEUS, Grant title: ERC 835297 - PROTEUS)

History

Usage metrics

    The Francis Crick Institute

    Categories

    Keywords

    Swanton FC00116911 Medical and Health SciencesGeneral & Internal Medicine

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC